Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
AstraZeneca
US Department of Justice
Fuji
Merck
McKinsey
Novartis
Express Scripts
Citi

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062226

« Back to Dashboard

NDA 062226 describes LAROTID, which is a drug marketed by Dr Reddys Labs Inc and Glaxosmithkline and is included in two NDAs. It is available from one supplier. Additional details are available on the LAROTID profile page.

The generic ingredient in LAROTID is amoxicillin. There are forty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 062226
Tradename:LAROTID
Applicant:Dr Reddys Labs Inc
Ingredient:amoxicillin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 062226
Ingredient-typePenicillins
Medical Subject Heading (MeSH) Categories for 062226
Suppliers and Packaging for NDA: 062226
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMOXIL amoxicillin FOR SUSPENSION;ORAL 062226 ANDA Dr Reddys Laboratories Inc 43598-209 43598-209-52 100 mL in 1 BOTTLE (43598-209-52)
AMOXIL amoxicillin FOR SUSPENSION;ORAL 062226 ANDA Dr Reddys Laboratories Inc 43598-209 43598-209-53 150 mL in 1 BOTTLE (43598-209-53)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength125MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength250MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength125MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Novartis
AstraZeneca
Harvard Business School
Chinese Patent Office
Accenture
Cerilliant
Julphar
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot